Pfizer’s high-stakes bet on antibody-drug conjugates (ADCs) has hit a speed bump. | Pfizer announced Monday that sigvotatug ...

The drug, acquired in Pfizer's $43 billion purchase of Seagen, did not outlast standard chemotherapy in a 703-patient study ...

Javelin Biotech today announced a landmark scientific publication, titled "Interconnected multi-microphysiological systems ...

Pfizer PFE has announced top-line data from a late-stage study which evaluated its investigational antibody-drug conjugate ...

Pfizer said an experimental drug it hoped could replace a widely used chemotherapy in one of the most common forms of lung ...

China's Innovent Biologics and U.S. pharma giant Pfizer have agreed to a global licensing and collaboration deal worth up to $10.5 billion to develop 12 early-stage cancer medicines, as global ...

By Maggie Fick BRUSSELS, June 23 (Reuters) - China has pulled ahead of Europe in pharmaceutical innovation and drug ...

Today, Zacks Investment Ideas feature highlights iShares Biotechnology ETF IBB, Novartis NVS, Pfizer PFE and Eli Lilly’s LLY.

Pfizer (NYSE:PFE | PFE Price Prediction) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a $128 billion market cap. Renowned for its ...

The ruling marks the end of a case that put Alnylam and Pfizer at loggerheads. In its response to the PMCPA, Alnylam accused ...

Pfizer remains in focus as healthcare stays steady during market weakness, with drug-pricing questions shaping the ...